Side-by-side comparison of AI visibility scores, market position, and capabilities
Merrillville IN regulated utility (NYSE: NI) at $5.5B 2024 revenue; $19.4B 2025-2029 capex plan for 8-10% rate base growth with Columbia Gas/NIPSCO brands and net-zero 2040 target competing with Atmos Energy for gas utility.
NiSource Inc. is a Merrillville, Indiana-based fully regulated utility company — publicly traded on the New York Stock Exchange (NYSE: NI) as an S&P 500 component — serving approximately 3.3 million natural gas customers and 500,000 electric customers across six states (Indiana, Kentucky, Maryland, Ohio, Pennsylvania, and Virginia) through its Columbia Gas brands and the NIPSCO (Northern Indiana Public Service Company) electric utility. NiSource employs approximately 7,700 people and operates through nearly 60,000 miles of natural gas pipeline and distribution infrastructure. In fiscal year 2024, NiSource reported operating revenues of $5.5 billion and net income of $739.7 million ($1.62 EPS), up from $661.7 million in 2023. NiSource provided 2025 non-GAAP adjusted EPS guidance of $1.85-$1.89 and announced an increased $19.4 billion capital expenditure plan for 2025-2029 targeting 8-10% rate base growth and 6-8% EPS annual growth. NiSource is committed to a net-zero emissions target by 2040, has reduced greenhouse gas emissions by approximately 72% from 2005 levels, and is on track to retire 100% of its coal assets by 2028, replacing them with utility-scale solar and renewable energy.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.